Projects per year
Personal profile
Area of Expertise
The first aim is to screen compounds that will attenuate the subjective and reinforcing effects of abused drugs as part of a NIDA-funded contract searching for effective treatment drugs for addiction to cocaine, methamphetamine, nicotine, and marijuana.
The second aim is to evaluate the potential abuse liability of novel designer drugs that are increasingly available as "legal" alternatives to controlled substances. We use drug discrimination procedures which assess the subjective effects of common drugs of abuse such as cocaine, methamphetamine, nicotine, and marijuana, with designer drugs like MDMA (Ecstasy), with opioids like morphine, or with hallucinogens like LSD. We also test the reinforcing/rewarding effects of drugs using the conditioned place preference and self-administration assays.
Education/Academic qualification
BA in Behavioral Science, The University of Chicago
MA in Behavior Science, University of Houston
PhD in Psychology , Utah State University
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 7 Finished
-
Using rodent behavioral models to identify substance abuse pharmacotherapies
Forster, M., Gatch, M., Sumien, N. & Shetty, R.
NIDA: National Institute on Drug Abuse
20/09/18 → 3/01/23
Project: Research
-
Evaluation of Synthetic Opioid Substances using the Drug Discrimination Assay
1/09/18 → 31/08/19
Project: Research
-
-
Evaluation of Synthetic Opioid Substances using the Drug Discrimination Assay
1/08/17 → 31/07/18
Project: Research
-
Rodent Testing to Identify Pharmacotherapies for Substance Dependence
NIDA: National Institute on Drug Abuse
4/01/16 → 20/09/18
Project: Research
-
Estrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: Potential mechanisms
Jung, M. E., Gatch, M. B. & Simpkins, J. W., Jan 2005, In: Experimental Biology and Medicine. 230, 1, p. 8-22 15 p.Research output: Contribution to journal › Short survey › peer-review
-
Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: Sensitivity to antagonism by quadazocine, naltrindole and β-funaltrexamine
Negus, S. S., Brandt, M. R., Gatch, M. B. & Mello, N. K., 1 May 2003, In: Drug and Alcohol Dependence. 70, 1, p. 17-27 11 p.Research output: Contribution to journal › Article › peer-review
-
Training and characterization of a quinine taste discrimination in rhesus monkeys
Aspen, J., Gatch, M. B. & Woods, J. H., 1999, In: Psychopharmacology. 141, 3, p. 251-257 7 p.Research output: Contribution to journal › Article › peer-review
-
Sex differences in the pentylenetetrazol-like stimulus induced by ethanol withdrawal
Jung, M. E., Wallis, C. J., Gatch, M. B. & Lal, H., Nov 1999, In: Journal of Pharmacology and Experimental Therapeutics. 291, 2, p. 576-582 7 p.Research output: Contribution to journal › Article › peer-review
-
Effects of GABAA compounds on mCPP drug discrimination in rats
Gatch, M. B., Jung, M. E., Wallis, C. J. & Lal, H., 18 Oct 2002, In: Life Sciences. 71, 22, p. 2657-2665 9 p.Research output: Contribution to journal › Article › peer-review